UNSPSC 51313308: Thiazinamium metilsulfate

This classification denotes a histamine-1 receptor antagonist with the molecular formula C18H23N2S.CH3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IA16WBX317, chemically known as 10h-phenothiazine-10-ethanaminium, n,n,n,alpha-tetramethyl-, methyl sulfate but more generally known as thiazinamium methylsulfate, which bears US NIH Compound Identifier 6015. European Medicines Agency schedules Thiazinamium metilsulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10971MIG.

UNSPSC 51313308 Thiazinamium metilsulfate is a Commodity code that shows little relevant recent activity in state and local procurement. The single recent opportunity posted under this code—Seminole County, Florida's IFB60459723LAS—solicits naloxone and drug deactivation systems for public health purposes, which falls outside the pharmaceutical compound scope the code nominally describes. The mismatch suggests either a tagging error in the county's procurement system or a fundamental misalignment between the UNSPSC taxonomy and how this jurisdiction classifies medical countermeasure procurement.

Seminole County posted the opportunity on June 30, 2026, with a response deadline of July 26, 2023 (the date appears internally inconsistent in the source), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB requires vendors to submit electronic bids through the county's e-Procurement Portal, include all shipping and delivery costs, maintain workers' compensation and commercial general liability insurance, and comply with drug-free workplace certification and E-Verify requirements. The contract awards on a fixed-fee basis with an initial two-year term and one-year renewal option, and includes a three-month probationary period allowing termination at will. Given the code's narrow pharmaceutical focus and the absence of additional state or local solicitations matching thiazinamium metilsulfate or similar pharmaceutical compounds, this Commodity code does not present a reliable basis for business development targeting at this time.